Write in a clean editor, then format for Journal of Clinical \& Translational Ophthalmology in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of Clinical \& Translational Ophthalmology is a peer-reviewed journal published by MDPI, covering Glaucoma and retinal disorders, Retinal Diseases and Treatments, Corneal surgery and disorders. Over its lifetime it has published 74 papers, which have received 66 citations.
| Publisher | MDPI |
|---|---|
| Reference style | Numbered (MDPI) Numbered — [1], [2] in the text 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Journal of Clinical \& Translational Ophthalmology 2023, 12, 45–58.
Formats any DOI in Journal of Clinical \& Translational Ophthalmology style. No sign-up. |
| Abbreviation (ISO-4) | J. Clin. Transl. Ophthalmol. |
| Publishes research in | Glaucoma and retinal disorders Retinal Diseases and Treatments Corneal surgery and disorders Ocular Surface and Contact Lens Ophthalmology and Visual Impairment Studies |
| ISSN | 2813-1053 |
| Citation impact (2-yr) | 0.84 |
| h-index | 4 |
| i10-index | 1 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | University of Michigan |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Glaucoma, the second leading cause of irreversible blindness globally, encompasses a heterogeneous group of ocular disorders characterized by the progressive degeneration of retinal ganglion cells. Pharmacotherapy remains the cornerstone of treatment, primarily aimed at reducing intraocular pressure (IOP) by decreasing aqueous humor production or enhancing its outflow. The therapeutic classes employed include carbonic anhydrase inhibitors,…
Glaucoma refers to a spectrum of progressive optic neuropathies and remains the leading cause of irreversible blindness worldwide. Its insidious onset poses serious challenges to conventional diagnostic methods and clinicians striving to detect early-stage disease for timely and effective intervention. Artificial intelligence (AI) has demonstrated its ability to process and analyze large datasets which can…
Glaucoma therapy aims at lowering intra-ocular pressure (IOP). Brinzolamide, a carbonic anhydrase inhibitor, is utilized as a second-line medication for treating ocular hypertension and primary open-angle glaucoma (POAG). The drug lowers the IOP making it a therapeutic agent against glaucoma, and due to its poor water solubility, is commercially available as Azopt®, a 1% ophthalmic…
In 1931, Von Euler and Gaddum isolated substance P (SP), an undecapeptide from the tachykinin family, from equine brain and intestine tissue extracts. Numerous types of cells, including neurons, astrocytes, microglia, epithelial, and endothelial cells, as well as immune cells including T-cells, dendritic cells, and eosinophils, are responsible for its production. The corneal epithelium, immune…
Peripheral ulcerative keratitis (PUK) is an inflammatory process causing thinning of the cornea, epithelial defect, and inflammatory infiltrates and is caused by several etiologies. This sight-threatening condition can indicate the presence of potentially fatal underlying systemic conditions, and, accordingly, warrants thorough investigation upon clinical presentation and immediate intervention in order to mitigate disease progression. This…
